PSMA PET/CT with Glu-urea-Lys-(Ahx)-[(68)Ga(HBED-CC)] versus 3D CT volumetric lymph node assessment in recurrent prostate cancer

por Giesel, Frederik L., Fiedler, H., Stefanova, M., Sterzing, F., Rius, M., Kopka, K., Moltz, J. H., Afshar-Oromieh, A., Choyke, P. L., Haberkorn, U., Kratochwil, C.
Publicado 2015

Impact of Primary Staging with Fibroblast Activation Protein Specific Enzyme Inhibitor (FAPI)-PET/CT on Radio-Oncologic Treatment Planning of Patients with Esophageal Cancer

por Ristau, J., Giesel, F. L., Haefner, M. F., Staudinger, F., Lindner, T., Merkel, A., Schlittenhardt, J., Kratochwil, C., Choyke, P. L., Herfarth, K., Debus, J., Haberkorn, U., Koerber, S. A.
Publicado 2020

Head-to-head Intra-individual Comparison of [(68)Ga]-FAPI and [(18)F]-FDG PET/CT in Patients with Bladder Cancer

por Novruzov, E., Dendl, K., Ndlovu, H., Choyke, P. L., Dabir, M., Beu, M., Novruzov, F., Mehdi, E., Guliyev, F., Koerber, S. A., Lawal, I., Niegisch, G., Debus, J., Haberkorn, U., Sathekge, M., Giesel, F. L.
Publicado 2022

Focal laser ablation as clinical treatment of prostate cancer: report from a Delphi consensus project

por van Luijtelaar, A., Greenwood, B. M., Ahmed, H. U., Barqawi, A. B., Barret, E., Bomers, J. G. R., Brausi, M. A., Choyke, P. L., Cooperberg, M. R., Eggener, S., Feller, J. F., Frauscher, F., George, A. K., Hindley, R. G., Jenniskens, S. F. M., Klotz, L., Kovacs, G., Lindner, U., Loeb, S., Margolis, D. J., Marks, L. S., May, S., Mcclure, T. D., Montironi, R., Nour, S. G., Oto, A., Polascik, T. J., Rastinehad, A. R., De Reyke, T. M., Reijnen, J. S., de la Rosette, J. J. M. C. H., Sedelaar, J. P. M., Sperling, D. S., Walser, E. M., Ward, J. F., Villers, A., Ghai, S., Fütterer, J. J.
Publicado 2019